DR. SOLLY E ELMANN MD
Prescription History 1447545421
Ophthalmology in Brooklyn, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. SOLLY E ELMANN MD, an active Ophthalmology specialist practicing in Brooklyn, NY. Our medical registry currently tracks 11 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,082 documented patient claims. Among these therapy options, the most frequently utilized medication is Prednisolone Acetate, which accounts for 365 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| Prednisolone Acetate | 365 | $55.60 | ▲ More than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 365 Medicare prescriptions for Prednisolone Acetate, about 2.7 times the volume of the typical New York prescriber of this medication (135). Medicare paid an average of $55.60 per fill, versus $52.63 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 413.1 30-Day Fills standardized to 30-day supplies 10,884 Days of Medication total across all patients in 2023 | |||
| Latanoprost | 270 | $14.80▼ below NY avg | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 270 Medicare prescriptions for Latanoprost, about 1.8 times the volume of the typical New York prescriber of this medication (149). Medicare paid an average of $14.80 per fill, versus $20.93 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 400.4 30-Day Fills standardized to 30-day supplies 11,736 Days of Medication total across all patients in 2023 | |||
| Ofloxacin | 193 | $23.11 | ▲ More than typical |
About Ofloxacin: This medication is used to treat eye infections. Show more ▾ Ofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. In 2023, this provider wrote 193 Medicare prescriptions for Ofloxacin, about 2.6 times the volume of the typical New York prescriber of this medication (73). Medicare paid an average of $23.11 per fill, versus $20.90 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 220.9 30-Day Fills standardized to 30-day supplies 5,823 Days of Medication total across all patients in 2023 | |||
| CombiganBrimonidine Tartrate/Timolol | 85 | $326.76▼ below NY avg | ▲ More than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 85 Medicare prescriptions for Combigan, about 1.6 times the volume of the typical New York prescriber of this medication (52). Medicare paid an average of $326.76 per fill, versus $403.34 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 105.3 30-Day Fills standardized to 30-day supplies 2,979 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 69 | $24.08▼ below NY avg | ≈ Typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 69 Medicare prescriptions for Dorzolamide-Timolol, about 77% of the volume of the typical New York prescriber of this medication (90). Medicare paid an average of $24.08 per fill, versus $32.93 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 109.4 30-Day Fills standardized to 30-day supplies 3,279 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 25 | $176.51▼ below NY avg | ≈ Typical |
About Brimonidine Tartrate-Timolol: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 25 Medicare prescriptions for Brimonidine Tartrate-Timolol, about the same volume as the typical New York prescriber of this medication (24). Medicare paid an average of $176.51 per fill, versus $303.99 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 35.3 30-Day Fills standardized to 30-day supplies 997 Days of Medication total across all patients in 2023 | |||
| XiidraLifitegrast | 22 | $719.32▼ below NY avg | ▼ Less than typical |
About Xiidra: This medication is used to treat dry eye disease. In 2023, this provider wrote 22 Medicare prescriptions for Xiidra, about half the volume of the typical New York prescriber of this medication (50). Medicare paid an average of $719.32 per fill, versus $945.82 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 22 30-Day Fills standardized to 30-day supplies 660 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 16 | $14.10▼ below NY avg | ▼ Less than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 16 Medicare prescriptions for Brimonidine Tartrate, about a quarter of the volume of the typical New York prescriber of this medication (61). Medicare paid an average of $14.10 per fill, versus $70.70 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 28.5 30-Day Fills standardized to 30-day supplies 840 Days of Medication total across all patients in 2023 | |||
| LumiganBimatoprost | 14 | $643.46 | ▼ Less than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 14 Medicare prescriptions for Lumigan, about 18% of the volume of the typical New York prescriber of this medication (77). Medicare paid an average of $643.46 per fill, versus $492.27 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25.5 30-Day Fills standardized to 30-day supplies 745 Days of Medication total across all patients in 2023 | |||
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 12 | $12.72▼ below NY avg | ▼ Less than typical |
About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾ This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. In 2023, this provider wrote 12 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about a quarter of the volume of the typical New York prescriber of this medication (49). Medicare paid an average of $12.72 per fill, versus $14.55 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 12 30-Day Fills standardized to 30-day supplies 136 Days of Medication total across all patients in 2023 | |||
| Difluprednate | 11 | $376.35 | ▼ Less than typical |
About Difluprednate: This medication is used to treat swelling and pain after eye surgery. Show more ▾ It may also be used to treat a certain serious eye problem (endogenous anterior uveitis). This medication belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 11 Medicare prescriptions for Difluprednate, about a quarter of the volume of the typical New York prescriber of this medication (40). Medicare paid an average of $376.35 per fill, versus $152.51 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19.5 30-Day Fills standardized to 30-day supplies 565 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. SOLLY E ELMANN MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Brooklyn, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NY prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
